Form4insider filings, from the source

SEC Form 4 · accession 0001645627-19-000001

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President
Period of report
Dec 27, 2018
Accepted (ET)
Jan 3, 2019 · 3:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 27, 2018P1,000$0.0214A26,620,597D
Common StockDec 27, 2018P1,000$0.0198A26,621,597D
Common StockDec 27, 2018P1,000$0.0198A26,622,597D
Common StockDec 27, 2018P1,000$0.02A26,623,597D
Common StockDec 27, 2018P2,000$0.02A26,625,597D
Common StockDec 27, 2018P1,000$0.0179A26,626,597D
Common StockDec 27, 2018P2,000$0.0179A26,628,597D
Common StockDec 27, 2018P1,000$0.0179A26,629,597D
Common StockDec 27, 2018P1,000$0.02A26,630,597D
Common StockDec 27, 2018P1,000$0.02A26,631,597D
Common StockDec 27, 2018P1,000$0.021A26,632,597D
Common StockDec 28, 2018P2,000$0.0188A26,634,597D
Common StockDec 28, 2018P5,000$0.0184A26,639,597D
Common StockDec 28, 2018P1,000$0.0184A26,640,597D
Common StockDec 28, 2018P1,000$0.0182A26,641,597D
Common StockDec 28, 2018P1,000$0.0195A26,642,597D
Common StockDec 28, 2018P2,000$0.0183A26,644,597D
Common StockDec 28, 2018P1,000$0.019A26,645,597D
Common StockDec 28, 2018P1,000$0.019A26,646,597D
Common StockDec 28, 2018P1,000$0.019A26,647,597D
Common StockDec 28, 2018P1,000$0.019A26,648,597D
Common StockDec 31, 2018P1,000$0.0179A26,649,597D
Common StockDec 31, 2018P1,000$0.0185A26,650,597D
Common StockDec 31, 2018P1,000$0.0185A26,651,597D
Common StockDec 31, 2018P1,000$0.0182A26,652,597D
Common StockJan 2, 2019P1,000$0.019A26,653,597D
Common StockJan 2, 2019P2,000$0.0189A26,655,597D
Common StockJan 2, 2019P5,000$0.0177A26,660,597D
Common StockJan 2, 2019P100$0.0189A26,660,697D

Table II — derivative securities

No Table II lines on this filing.